-
Phase 3 Trials of Tolebrutinib in MS Forms to Include Digital Measures
Now, I fully admit to not being able to understand how the ‘digital measures‘ work, but I’m v. impressed at the speed Tolebrutinib is going thru testing. It was only on Sept 2020 that we were reporting on its effect in slowing down myelin loss in mice! Now, clinical trials have reached Stage 3 in us lot!!
Maybe, u aren’t?| Lat me know pls. X
-
0 Replies
Sorry, there were no replies found.
Log in to reply.